This study confirmed that MTO1 mutations are associated with a mitochondrial disorder, characterized by hypertrophic cardiomyopathy, lactic acidosis, and MRC deficiency, albeit with a broad range of severity and frequent involvement of brain, possibly depending on the treatment. This evidence concerns the gene MTO1 and hypertrophic cardiomyopathy.